Navigation Links
Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results
Date:1/31/2008

Thursday, February 7th, 11:00 a.m. EST

WALTHAM, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, February 7th, 2008 at 11:00 a.m. EST, to report third quarter fiscal year 2008 financial results and to provide a quarterly update of the Company.

This call is being webcast by Thomson/CCBN and can be accessed via Repligen's website at http://www.repligen.com. If you are unable to access the webcast via the internet, you may also listen to the live broadcast by calling (888) 713-4216 for domestic calls and (617) 213-4868 for international calls. Participants must provide the following passcode: 98169734. For those who cannot participate in the live conference call, an archive of the audio webcast will be available shortly after the call and may be accessed at http://www.repligen.com.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from http://www.repligen.com.

This press release contains forward-looking statements which ar
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cardium Announces $5.3 Million Registered Direct Offering
2. Hologic Announces First Quarter Fiscal 2008 Operating Results
3. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
4. Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity
5. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
6. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
7. Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
8. Genelabs Technologies, Inc. Announces Resignation of President and CEO
9. CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board
10. BioHorizons Announces Agreement to Purchase Implant Logic Systems
11. AlphaVax Announces New CMV Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Die Übersetzungen wurden von PRNewswire ... der englischen Version handelt es sich um ... Teilnehmer einer groß angelegten Asthmaumfrage halten ihren Zustand für ... -Definition [1] als kontrolliert gelten können ... von vier Denkweisen zugeordnet werden können, die alle von ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... Can economic incentives such as gift ... of the public to increase their donations of blood? ... Carey Business School Assistant Professor Mario Macis says ... large body of recent research that supports their argument, ... issue of Science that the World Health Organization and ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Patheon ... manufacturing services to the global pharmaceutical industry, will host ... Novel Approaches to Testing” on Tuesday, June 4, 2013 ... pharmaceutical manufacturers are required to comply with regulations for ... practices with limited scientific underpinning and little evaluation of ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2
... Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now... -- DALLAS, November 1, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
... ... ... var shortURL ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for ...
... hundreds of FDA inspectors; now it trains thousands of ... global team of FDA compliance experts, EduQuest is presenting ... training course for quality managers and regulatory specialists December ... (near I-95, Amtrak rail lines, and the Philadelphia airport). ...
Cached Biology Technology:Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 2Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 3Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 4Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 5Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 6Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 7Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 8Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 9Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 10Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 11Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 2Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 3Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 4Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 5Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 6Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 7Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 8Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 9Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 10Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 11Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 12Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 13Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Comply with Latest FDA Expectations for Validation and Part 11 2
(Date:5/24/2013)... grow by avoiding detection and destruction by the immune ... eliminate cancer cells; however, there are many factors that ... T cells are immune cells that function to suppress ... Journal of Clinical Investigation , researchers led by ... cells that infiltrate tumors express proteins that can be ...
(Date:5/24/2013)... from around the world today issued a stark warning ... one or two generations, the majority of the 9 ... handicap of severe pressure on fresh water, an absolutely ... This handicap will be self-inflicted and is, we believe, ... underlying problems led by mismanagement and sent a prescription ...
(Date:5/23/2013)... than 284 million tons of cargo, transit the Panama Canal ... for the Panama Canal Authority. Each time a ship passes ... from Gatun Lake, which is also a source of water ... , However, the advent of very large "super" cargo ships, ... has demanded change. The Panama Canal is being expanded to ...
Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3
... NOVEMBER 16, 2009 Experts in soil science and representatives ... Congressional educational briefing, "The Essence of Earth and Wine: Terroir" ... House Office Building (Gold Room). Experts in ... -- how the balance of vineyard management and soil site ...
... Oak Ridge, Tenn., Nov. 16, 2009 -- An ... by the Department of Energy has made the "Jaguar" ... Laboratory, Jaguar is the scientific research community,s most powerful ... most difficult problems. The upgrade, funded with $19.9 million ...
... most people, you probably think chemistry is too difficult to ... any fun. But chemistry offers a magic and elegance to ... the fundamentals of digestion (as when good pizza goes bad!) ... Monty L. Fetterolf, both professional chemists and experienced educators, challenge ...
Cached Biology News:Soil experts to discuss terroir, the link between Earth, wine on Nov. 19 in DC 2Oak Ridge 'Jaguar' supercomputer is World's fastest 2Oak Ridge 'Jaguar' supercomputer is World's fastest 3Explore the science of familiar things -- and discover the 'Joy of Chemistry' 2
Carrier Serum...
The Lambda Control Kit contains lambda DNA and two 25mer primers, which can be used to amplify a 500bp fragment. The lambda DNA is purified by CsCl gradient centrifugation and organic extraction foll...
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
... Klein Taq is a derivative of ... N-terminally truncated Thermus aquaticus DNA polymerase. Expressed ... translation initiates at Met236, bypassing the 5'-3' ... The enzyme reveals a highly active and ...
Biology Products: